These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

913 related items for PubMed ID: 18215470

  • 1. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 2. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C, Wester M, Yassouridis A, Wiedemann K, Kellner M.
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [Abstract] [Full Text] [Related]

  • 3. Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder.
    de Kloet CS, Vermetten E, Geuze E, Wiegant VM, Westenberg HG.
    J Psychiatr Res; 2008 Feb; 42(3):192-8. PubMed ID: 17222428
    [Abstract] [Full Text] [Related]

  • 4. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 7. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 8. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 01; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.
    Ströhle A, Scheel M, Modell S, Holsboer F.
    J Psychiatr Res; 2008 Oct 01; 42(14):1185-8. PubMed ID: 18342888
    [Abstract] [Full Text] [Related]

  • 13. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.
    Eur Neuropsychopharmacol; 2009 Jun 01; 19(6):409-15. PubMed ID: 19327969
    [Abstract] [Full Text] [Related]

  • 14. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Jun 01; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 15. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, Rupprecht R, Bondy B.
    Psychoneuroendocrinology; 2006 Sep 01; 31(8):1019-25. PubMed ID: 16890377
    [Abstract] [Full Text] [Related]

  • 16. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 17. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):803-7. PubMed ID: 8750038
    [Abstract] [Full Text] [Related]

  • 18. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W.
    Biol Psychiatry; 2002 Dec 01; 52(11):1102-12. PubMed ID: 12460693
    [Abstract] [Full Text] [Related]

  • 19. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 01; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 20. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug 01; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.